My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

24.21 -0.07 (-0.29%)

Official Closing Price Updated: 7:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited American Depositary Shares

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

30 31 Next >

Alvotech and Teva Announce Acceptance of U.S. Biologics License Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)

January 06, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Alvotech and Teva Announce Acceptance of U.S. Biologics License Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)

January 06, 2023

From Alvotech

Via GlobeNewswire

Jazz Pharmaceuticals Files Patent Infringement Against Generic Drugmakers In New Jersey's District Court ↗

January 05, 2023

Jazz Pharmaceuticals (NASDAQ: JAZZ), a drug company behind the CBD-based medication Epidiolex, recently filed a lawsuit against Teva Pharmaceutical Industries Ltd (NYS

Via Benzinga

4 Analysts Have This to Say About Teva Pharmaceutical Indus ↗

November 23, 2022

Via Benzinga

Analyst Ratings for Teva Pharmaceutical Indus ↗

November 23, 2022

Via Benzinga

What 4 Analyst Ratings Have To Say About Teva Pharmaceutical Indus ↗

November 23, 2022

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

January 04, 2023

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

2023 Kick-Off With Apple Losing $2T With Big Option Trades On GLD And XLE ↗

January 03, 2023

While the tenor was more bearish, the late-day rally found the market close to where it finished 2022.

Via Talk Markets

Teva to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 03, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

2 "Safe" Stocks That Are Anything But ↗

December 30, 2022

Sometimes, business models that sound safe still fail to deliver for shareholders.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

December 29, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Update on U.S. Regulatory Status of AVT02, Alvotech’s Proposed High-Concentration, Interchangeable Biosimilar to Humira®

December 22, 2022

From Alvotech

Via GlobeNewswire

My Top 5 Portfolio Holdings for 2023 ↗

December 21, 2022

This mix of growth and value stocks can outperform in a challenging environment.

Via The Motley Fool

Looking At Teva Pharmaceutical Indus's Recent Unusual Options Activity ↗

December 09, 2022

Someone with a lot of money to spend has taken a bearish stance on Teva Pharmaceutical Indus (NYSE:TEVA). And retail traders should know. We noticed this today when the big position showed up on...

Via Benzinga

Is Prometheus Biosciences a Good Stock to Buy Right Now? ↗

December 09, 2022

This biotech stock just jumped over 180% in a single day, and investors want to know if there could be more big gains ahead.

Via The Motley Fool

3 Unparalleled Stocks to Buy That Have Never Been This Cheap ↗

December 05, 2022

These three leading companies are ripe for the picking and may never be this cheap again.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

November 29, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

November 28, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Burlington Stores To Surge Over 21%? Plus Wedbush Slashes PT On Jack In The Box ↗

November 23, 2022

Barclays raised the price target on Burlington Stores, Inc. (NYSE: BURL) from $164 to $230. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Burlington shares fell 0.1% to...

Via Benzinga

AbbVie Finalizes To Pay Around $2.4B In Settlement Against US Opioid Lawsuits ↗

November 22, 2022

Via Benzinga

Stocks Move Higher As Wall Street Eyes China Lockdowns ↗

November 22, 2022

The Dow Jones Industrial Average is up 271 points midday, while the Nasdaq Composite and S&P 500 Index are firmly higher as well.

Via Talk Markets

Teva Finalizes Nationwide Opioid Settlement Terms

November 22, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

Why Is Imago Biosciences (IMGO) Stock Up 105% Today? ↗

November 21, 2022

Imago Biosciences (IMGO) stock is rocketing higher on Monday following news that Merck (MRK) is acquiring the company for $36 per share.

Via InvestorPlace

TEVA Stock Alert: What to Know About Teva Pharmaceuticals’ New CEO ↗

November 21, 2022

Teva Pharmaceuticals (TEVA) stock is sliding on Monday after the company announced Richard Francis as its newest president and CEO.

Via InvestorPlace

Teva Announces Appointment of Richard Francis as President and CEO

November 21, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva Announces Unique Collaboration with Rimidi to Expand the Reach of its Respiratory Digital Health Platform

November 14, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva Announces Unique Collaboration with HealthSnap to Expand the Reach of its Respiratory Digital Health Platform

November 14, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

AMD To Rally Around 39%? Here Are 5 Other Price Target Changes For Monday ↗

November 14, 2022

Baird raised Advanced Micro Devices, Inc. (NASDAQ: AMD) price target from $65 to $100. . Baird analyst Tristan Gerra upgraded the stock from Neutral to Outperform. AMD shares rose 5.7% to close at...

Via Benzinga

Eli Lilly's Migraine Drug Infringed Teva's Patents, Ordered To Pay $176M ↗

November 10, 2022

A federal jury has asked Eli Lilly And Company (NYSE: LLY) to pay Teva Pharmaceuticals International GmbH $176.5 million after a trial to determine whether its migraine drug Emgality infringed three...

Via Benzinga

Adding $100 to These 5 Stocks Would Be a Genius Move Right Now ↗

November 09, 2022

You don't need a large pile of cash to begin building wealth on Wall Street.

Via The Motley Fool

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

30 31 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.